Viewing Study NCT00390520


Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-01-24 @ 12:02 AM
Study NCT ID: NCT00390520
Status: COMPLETED
Last Update Posted: 2020-02-11
First Post: 2006-10-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes View
None vildagliptin View
None glucagon View
None hypoglycemia View